CINXE.COM

<!DOCTYPE html><html lang="en-US"><head><title>Just a moment...</title><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="robots" content="noindex,nofollow"><meta name="viewport" content="width=device-width,initial-scale=1"><style>*{box-sizing:border-box;margin:0;padding:0}html{line-height:1.15;-webkit-text-size-adjust:100%;color:#313131;font-family:system-ui,-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Helvetica Neue,Arial,Noto Sans,sans-serif,Apple Color Emoji,Segoe UI Emoji,Segoe UI Symbol,Noto Color Emoji}body{display:flex;flex-direction:column;height:100vh;min-height:100vh}.main-content{margin:8rem auto;max-width:60rem;padding-left:1.5rem}@media (width <= 720px){.main-content{margin-top:4rem}}.h2{font-size:1.5rem;font-weight:500;line-height:2.25rem}@media (width <= 720px){.h2{font-size:1.25rem;line-height:1.5rem}}#challenge-error-text{background-image:url(data:image/svg+xml;base64,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);background-repeat:no-repeat;background-size:contain;padding-left:34px}@media (prefers-color-scheme:dark){body{background-color:#222;color:#d9d9d9}}</style><meta http-equiv="refresh" content="390"></head><body class="no-js"><div class="main-wrapper" role="main"><div class="main-content"><noscript><div class="h2"><span id="challenge-error-text">Enable JavaScript and cookies to continue</span></div></noscript></div></div><script>(function(){window._cf_chl_opt={cvId: '3',cZone: "aacrjournals.org",cType: 'managed',cRay: '8e70101bef654b62',cH: 'oh0BSWtDcvN_uh9cFGknUWxZOml3Vnh._2GRB21eFmg-1732353412-1.2.1.1-J.LDFL3n8cuAP6OdWziMofcK2XTKxyIM.cgOm4AQuu6wYnBv0jGz1OdCC6Tc5zBY',cUPMDTk: "\/clincancerres\/article\/26\/3\/545\/83188\/Pan-Tumor-Pathologic-Scoring-of-Response-to-PD-L-1?__cf_chl_tk=CN7LBYJBECpcYpV69PZHuJWpRhU9gnoFXJfne1pNR0E-1732353412-1.0.1.1-lRZFQ7I8ej2DMy_0t.8PF27b1dz2KpCeQcYGE8zgRuc",cFPWv: 'g',cITimeS: '1732353412',cTTimeMs: '1000',cMTimeMs: '390000',cTplC: 0,cTplV: 5,cTplB: 'cf',cK: "",fa: "\/clincancerres\/article\/26\/3\/545\/83188\/Pan-Tumor-Pathologic-Scoring-of-Response-to-PD-L-1?__cf_chl_f_tk=CN7LBYJBECpcYpV69PZHuJWpRhU9gnoFXJfne1pNR0E-1732353412-1.0.1.1-lRZFQ7I8ej2DMy_0t.8PF27b1dz2KpCeQcYGE8zgRuc",md: "1F1W_jKZyX3A3ykRrTko5Fu_VH56DVXpoqxPHPBqt8w-1732353412-1.2.1.1-ySlUk_VNnLS_JQmdFP4PcbHHkl4RbGbGcP7Bt8zapoYTuBrOJU0gZ_oHsTfH7.0WvLl4YFmId6nXMAmKghzARvz4CMDJdWI2GjToCJArxnDfOrmaRICpMB0fqUEpniagMHQbyTUNDfOoF7OZQYssGLSSSbhcIE7B.uKL4HQzF1u59DDsnj6JarRqgeQw_GqlxSAhLNqLuer9x4TI7AvaTQQo2AxokdQMDpRnpheyW1y7gehCC6FDbakicoLjtX0HR_bR1PyX0VqOuBoeKeu2mqoi8d1BRgZfTSTzPrkb5AZO2y9Eq1.i0AWgVPKprWo2I9xLKV1wmBbIP5PrzYuH2srhxku2g7JgDYG3D_RD1LtJqhUtS6NnaacRDaqXNiuxpNIleM7ZsXkShiVgfTD65qHdxKhTNCRkFACJ0NTBgG7U3iF8Xb_o74P0ZcsvpRMM27ldPnN8tJuWbGShzM6vNcIcsShxK87K491zr.wM7xMX3evYZSid3njk4CFjJE3MtUNun6LtlmqQ0upfjygszbMpcPz1NSz92jsVneuV.GSPUTgMqt6gQ19LhSdx89Ft9c8c7aWkqSQpUsaKCB4hfVmJAmHNRXluPfo9EP5UgQNKffSYHARjRpGQqyZfLm551S1ReYOKmxC7tQsHul8Cew6UVzPn90Ee5hO13TERkz6dbKV9VxNlZ4vPQCu_okDxWV5Qmnr_k.8YsCq6T.canjwtBCggMOJg46tUy3ozJeI0XTm4ME7lHmnmqYacjx_Tc97YcFo9j8Uaf9EirDuxU4Ew8ERC8Ejf7QL0L9rUiP_pwS_RRYsZuBJv5lBIA7cB3rHqA.tI4daRkyW92VvWFJnFRE1okh52rMPS25vwWZLaEACB8299cGlPwfoY0WxAa6IQ61B.Vknv26F5hgbwOcTyQfxWBdKJ4lgiMloFVtkG5fyd.9xBfHAOOKaA_h6PmVSCO2_2d5b3NesPHJhK1pr6Zfvyxtggu.PVjkmGjBHp7xk7KrX5H2FoUw5sPKcsgQDTG8hbDaLKUrgdYQDgPUdImISQBCUmOjWC5oBpJtS6S1Ape25eeUdAW_uXI1yV7kF_z8jLCf3AKoVvnvkjmXsia6N8eV.k5F86lGGsdgVCKxF5TtM9S11Hp4OO6PziS5D9TrmK1CUrblb.7Lkx.4twsEpOlbqWWxWf_IBwOpRgK.WfjWSqLNFLcrRMYD8LZax1nA7ntrNNxBOneiybftkdwJBVa0FMe5fy4VgrJFAGwBSXSE2HXxPjxwIUc_N7BbtXJKIjPSkeFfJPVWfhRuZrzLHpcVMBmikNcmuIJK5qxjaw4zrGEwpLHH8Kgjcu6QYMGjvULuzB4gD4kaFhahI2yHfU96F8WRPomGdyvX5kaNhuAu49e.DFuDFjIwMZaEjNeNW3C6WWeHMfrx23ZkR2a_i4yy7sZdaMdiFIPNOErdita6J4RSL4iWp_WaZIBwIxHyXvmptST.XJbFXmq4rR6bt1gVQ5lBEXM2J8TJR_XKxgskpLhocevzZQH9HM49eH6aeTmPB1.fEHyhUF2RfPIZY3e8GXd6iGArWXzzM5Xjqn_pv0CXeEt5zz26DRGtdRVXO80NVIenRD7gbfF6SIMBGaUW05QZ4hj2mn5t4.XZLAizc21hv1NmYyrBtelXgvAmxOx1jxZrr0jfne.j_Y0Sn095jyjYTVUPH5p9c1_YmK529qMXyZ1qO.uA1H0g9PYQG4oXSX3.Hp4SXR0yiqk0IWCXSoTGohvholn0xhgnO0cXvrvGIcDLDCqSHCPuALjjoIB3eob13l_YEpM0JvA7Hlq77f79Ewwzqcts5HdIqCOI8JK7uDhBhX9EqP9aR7kdq1taYiRN4ygGPHrWijhMIG3YEmxdThl_Fl324jXhB4VZHYG67x2p41kFiFj41wssNY5t_b7djDuwK2a3zPSZcGP1sXbJ6ky.45sXoNLPU4xJyqJMqhDsZJSGoAnmT8.gbE0NvEWvXg.U_.Q7RM8m1RBIbU0KOa8OIff5ErWlzuhcSv1s_Ckkn3AwgLsvqQL.jJJAjxAi8.j6mYxzZcOGbuBpKbw91wk7qzOXMm1Vd3myoP.IN_W3Vm_4BehEXeJg6b6TqWP5BL7KFQgV4QgZe2B9JJoIyZgRfgwWTa8cQNGHwUm1B8ggIArHdAEuB3eORscfPa2rlxSJxNQLwaFfLpdxjPOVOrOi6bo6bxWCE0Go.RYzBmGHbSSWWNjNnoUt9u6ubUnptNLBXRB0jaQReTSiNaDsL_A5p15qlw.6Gxj1A7.M2zCLlxa5098JNDRHImeFDuBdHBDZgW2_VqXNEyc0ZhaJ7h6JP__.TrpeGTjTsNrLT5dhjbtx5BY2r0yhX0UnNSVGwWGp.3JhjZwPLL8146nIgUOz6MmwmUvp7fmLHMBQz3PFGeRfPlNG6AyaKnRgNs3EYTlLpnVeOXyYj_fem41.1.04ETWvIkvU_zhjBcBBuxTNhxBkomgAquBWFKwsqOSrqDFtLt2DAoJftXJars0mr_DtIQeuZX4R3Toz_jKA4.czRSi8s1Ss3VT0s3Z_7q__ZPbsaxrFTDcPtYuL8zN282hkXhu4UIZJa0ofEc0hF1Lmu2A.fI9T6JMu7y.1xncZzRJo2NndOb8px6UDtUSSvoJVQV_iMqO.nBEQu1vVlLq6BrYXCPGXM3C8sR16weMyqjaWMs4C4sBz0oiPqiKPfo78DGWoabRABv_k4zPRrXano2SoevqYhhW1xLiSZTcTvRjBikhL_EVr2F1pL554vw0roYt2NgGr.ykTI3AJLSYbcjrOmLcB4zGhD_im.dNxAdYFIGptkh6iVwOabOz4T36FCrX3Hj9txMsU0E83xu1d1QMlcuzTiMjtqjE7Hm5fZS4mKMsHHGm1GXZBMkl_Hc_e.8D6F_ztPWXTL4RZAmwZL40e8rGJNM_DR3vF8J40kbbkFwa8kVuDnKvslU1WrZsroFT1_w_qcjNnhIPy2QN_.WHFgfeJcqoieCxEmRF6.1zDbmlfIM84PxZo.vjjnW4h.V2OCfkERRnb9UdvPU1sWHU_4ab_O05N5tOIzsRGqbNt1Cu0qICObzIUCYzJU2KPsFplWmsb8KZDWMRmRbg_op6b_s",mdrd: "VUSVrc6MTh9LGEW6Pgfldb3YVEwPg96VL4IaMphBrNU-1732353412-1.2.1.1-ubnuomBGE4bXPkwUbopdJHvMydPzsP5kTYGW7gdPj8TChhf2wSBzKjdLsJnfj1_FW299_c2WyCkDm1kNfxebhJhOmilFeld8W7qMF2ZcEDsQinsM1HulwRlEwhZE_UmCl6Q9oQ1fb_7fSV7_rmlVSo7u_flmJ7IBYluO7sR343QpFLlZQkq__CyBcDNC_W9g7ObG5PdqpdIDds1137eyqmtoPL9YYCmJgaFfoRyTLTd9KQD87Vl6Pb1V_iKD9qC6ETF4j9wTElsU2gHie_A3sBg2ddu4s.uDzbujsXl6VEPxt19JwrMGAPDA50bgLUlK5bkbDC7yeRZvnENinlp8o.qZy_XCUN1JYlReGU6LYAuyRYNp6YHDp7MNqGnbpmxjuWkvVbGy_Lxy1J_YZlMlRbWG9JLpgVPLNkW.7Wj5ON24My4gtvxiXVTCD8mUJPS_PzCLNWY_y8VwQ604L5j0a2BaZYES0XJf0rxTHETT4FB9K_iTm6PAZOWWpFmFJAMJw5LyM7mWJJzwBgd3IOt5u2WPtiSMG_xHxgu4sgy6K4IA.kvlEPh9Fxh0V4hrUMG9mYwUG659Ydu7aQEtcFS1V4J.laCYM2mH03NcpiDfudL9BrZeOR.2X37SQTuAZPIJ3fQbhK4.z1KGSr_sbooq.M11MIIloLRQ8KL8HkR1BKCzsBsyOVSdNqoGLfkD4phN99g2vJM_aInpql1meS6iRWe8xsV9TKDrmfkjGkC0IFrKkL7VwcOo_4D5t.YAYxv5cHV.ehl5Njtk1253zl7oMo_F3_7I5_LYJ9YjrRlJV4KeXVbULgMW8CU3znXP.6e9cj6gHgbF5wrnJW3Xju3MU_arH3FzxIntmXvRz4LNbd8kXwF2pW5ZK_1XLhBS7upU9TB_uckVONFkEx782ZTVz6BdEQ1IQm1qefnV.QsVzkv.xyCmYdbJBNibcRsMBARL_2NeJ5.FjbdQ6P1.LZ_RvylbWjX0yOMC4MqdTbkWXU3DbdlrrnAYztmUUyykyVEWkA2JyFyqNCzv7EFEOXMBjdsf2oG66LFKSdXsAATWrtLaqGQuyuRFEXy7J_56hsQFwoKyqMQZIC4u4l7i5Ts562G6T53zQW8f6B8r1e1AdGPsKFqkiuuJ49I7a5D3RbWTFHjDVwVy7tp.pmsfnAkGdt.YiSVOBnpNMsyXf51FXxgnxRIip11E4pKm8BY0kAkeXmvXFi0teu.u5OTp_cAg8BCpgsAC.R8arXz4IdXmkj6hQuEAoYDO9bfrJbLxHKJXIOpgc0V4NZcBaTDerjhaeq4pMW4e8aEr8ilUu_buSmTp6mvBkB5SCZsMmu7Gu1YIGf58eMmcUy6FZVoQqgezf2Np7ZmmSpe0xFJHIokMfapNwZgv.3vD605_LK4RCvvrmZ3Ocp_RGNipoIgkKJI8npmNTf5igK3xeCWRIBN_5pfDV9yjlRudLrjzd65dSimFJ6YFZEzE.5TtXQqaceRPQbfR86X__MzWIhSJbjztPJD0RtJ68E0C5kj47d1bgKGjoALYeflqxSC2p.vrWNKWPUBwU6b5cKynud_rhkXRQJeo4vGiHbafEWiN.3zvCYoFtTimnXG5jhxeh5GulN.DzgVqljLDArFj.SdkUIcrW_5X998SPnkH6GaAbPW7FTciRlJNUtSHWhea2JRI19zEqRHPFfC9m_BqFA_dBEosrp8iqQwXyJ7D8IeJJhpMcziVNMtvy3YFqgXofR1ZK8uDrhD8nWq0ja_qnEio3TFSt5a4g33UVOtc6ybBLQXDTzMc1fLFz.UoLswRmOjhmejuAOAazRiX7.9G0E9zGjrKNlhVKFwrMvf4EkaH0v4b1avdX80GgCExS3rqMS.Qq0iV2s1FXH3H2Oxn6Kzh.ZAoSuSUspkgixeYKi6O._V6Qq18eiFX4FcxCOQBuJ._YQFpNQJZKRAM.l7RmzsxviR624iiKQqvrag_K7_Q4rmtSREe"};var cpo = document.createElement('script');cpo.src = '/cdn-cgi/challenge-platform/h/g/orchestrate/chl_page/v1?ray=8e70101bef654b62';window._cf_chl_opt.cOgUHash = location.hash === '' && location.href.indexOf('#') !== -1 ? '#' : location.hash;window._cf_chl_opt.cOgUQuery = location.search === '' && location.href.slice(0, location.href.length - window._cf_chl_opt.cOgUHash.length).indexOf('?') !== -1 ? '?' : location.search;if (window.history && window.history.replaceState) {var ogU = location.pathname + window._cf_chl_opt.cOgUQuery + window._cf_chl_opt.cOgUHash;history.replaceState(null, null, "\/clincancerres\/article\/26\/3\/545\/83188\/Pan-Tumor-Pathologic-Scoring-of-Response-to-PD-L-1?__cf_chl_rt_tk=CN7LBYJBECpcYpV69PZHuJWpRhU9gnoFXJfne1pNR0E-1732353412-1.0.1.1-lRZFQ7I8ej2DMy_0t.8PF27b1dz2KpCeQcYGE8zgRuc" + window._cf_chl_opt.cOgUHash);cpo.onload = function() {history.replaceState(null, null, ogU);}}document.getElementsByTagName('head')[0].appendChild(cpo);}());</script></body></html>